US regulator says too many drugmakers chasing same cancer strategy - Reuters

Reuters

US regulator says too many drugmakers chasing same cancer strategy Reuters CHICAGO A new type of cancer drug that takes the brakes off the body's immune system has given drugmakers some remarkable wins against the deadly disease, but a top U.S. regulator says too many companies are focused on the same approach. and more »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHSW4m0FoRcqkWFUMEOYfw7RBNMqA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779130905175&ei=Q7ZaV8C4AoLd3AHh45sQ&url=http://www.reuters.com/article/us-health-cancer-fda-idUSKCN0YW15T
via IFTTT